-transparent.png){kind=logo}
We found that staurosporine, a potent inhibitor of protein kinase C, inhibits induction of ornithine decarboxylase (ODC) and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate (TPA) in CD-1 mouse skin. When applied 5 min either before or after treatment with TPA, 1 microgram of staurosporine cause about 56% inhibition of ODC-induction by 5 micrograms of TPA. However, staurosporine did not inhibit TPA-induced epidermal hyperplasia. In two-stage carcinogenesis, staurosporine at 1 microgram was applied 5 min before application of 5 micrograms of TPA to the initiated skin: number of tumors was suppressed by about 40% although the incidence was not affected. No tumors developed when staurosporine alone was applied to the initiated skin.
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
March 1992,
Carcinogenesis,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
July 1989,
Carcinogenesis,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
October 1987,
Biochemical and biophysical research communications,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
June 1990,
Cancer letters,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
October 1990,
Carcinogenesis,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
December 1989,
Molecular pharmacology,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
November 1988,
The Journal of investigative dermatology,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
July 1985,
Biochimica et biophysica acta,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
January 1991,
Molecular carcinogenesis,
S Yamada, and
K Hirota, and
K Chida, and
T Kuroki
August 1980,
Photochemistry and photobiology,
